Disruptive collaboration gains momentum in healthcare [Sponsored]
The ViVE conference highlighted some of the exciting developments in healthcare such as making drugs more affordable, interoperability, improving home care and holistic health.
Category: Civica Rx
The ViVE conference highlighted some of the exciting developments in healthcare such as making drugs more affordable, interoperability, improving home care and holistic health.
Civica Rx plans to make lower cost versions of three branded insulin products, biosimilars that are expected to reach the market in 2024. In addition to $30 vials, Civica plans to sell pen cartridges at $55 for a box of five.
The company, launched by SSM Health, Presbyterian Healthcare Services and Intermountain Healthcare, aims to create a marketplace for digital tools similar to the application stores on smartphones so that health systems can test and implement new solutions in weeks rather than months.